Jenoptik 미래 성장

XTRA:JEN - 애널리스트의 미래 추정치 및 과거 재무 데이터 (EUR Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	1,204	117	105	189	7
12/31/2025	1,140	96	97	181	9
12/31/2024	1,117	92	52	155	9
9/30/2024	1,112	84	100	190	N/A
6/30/2024	1,102	80	102	184	N/A
3/31/2024	1,088	76	69	155	N/A
12/31/2023	1,066	73	79	167	N/A
9/30/2023	1,051	70	72	154	N/A
6/30/2023	1,038	68	69	152	N/A
3/31/2023	1,006	70	87	170	N/A
12/31/2022	981	62	63	143	N/A
9/30/2022	929	75	56	130	N/A
6/30/2022	869	81	48	113	N/A
3/31/2022	809	91	38	92	N/A
12/31/2021	751	91	52	98	N/A
9/30/2021	630	69	56	101	N/A
6/30/2021	616	58	47	89	N/A
3/31/2021	602	37	48	87	N/A
12/31/2020	615	33	46	90	N/A
9/30/2020	765	48	69	113	N/A
6/30/2020	801	54	94	143	N/A
3/31/2020	836	57	84	136	N/A
12/31/2019	855	68	64	109	N/A
9/30/2019	837	78	43	90	N/A
6/30/2019	833	78	47	91	N/A
3/31/2019	829	82	75	118	N/A
12/31/2018	835	88	94	135	N/A
9/30/2018	814	82	81	119	N/A
6/30/2018	784	83	N/A	97	N/A
3/31/2018	774	80	N/A	95	N/A
12/31/2017	748	73	N/A	96	N/A
9/30/2017	719	62	N/A	94	N/A
6/30/2017	706	55	N/A	107	N/A
3/31/2017	690	56	N/A	103	N/A
12/31/2016	685	54	N/A	100	N/A
9/30/2016	674	51	N/A	108	N/A
6/30/2016	679	51	N/A	102	N/A
3/31/2016	681	48	N/A	101	N/A
12/31/2015	669	49	N/A	85	N/A
9/30/2015	658	46	N/A	69	N/A
6/30/2015	623	40	N/A	72	N/A
3/31/2015	599	39	N/A	53	N/A
12/31/2014	590	38	N/A	46	N/A
9/30/2014	588	42	N/A	56	N/A
6/30/2014	600	45	N/A	37	N/A
3/31/2014	605	44	N/A	41	N/A
12/31/2013	600	44	N/A	61	N/A

애널리스트 미래 성장 예측

수입 대 저축률: JEN 의 연간 예상 수익 증가율( 12.3% )이 saving rate( 1% 보다 높습니다. ).

수익 vs 시장: JEN 의 연간 수익( 12.3% ) German 시장( 21.1% 보다 느리게 성장할 것으로 예상됩니다. 21.1% 연간).

고성장 수익: JEN 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: JEN 의 수익(연간 4.4% ) German 시장( 5.6% 보다 느리게 성장할 것으로 예상됩니다. 5.6% 연간).

고성장 수익: JEN 의 수익(연간 4.4% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: JEN 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.6 %).

Jenoptik 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Price target decreased by 8.4% to €32.16

Price target increased by 8.5% to €33.30

Price target increased by 8.4% to €32.20

Price target decreased to €31.00

Consensus EPS estimates increase to €1.45

Recent updates

Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Price target decreased by 8.4% to €32.16

Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New minor risk - Dividend sustainability

Investor sentiment deteriorates as stock falls 17%

Jenoptik AG to Report Fiscal Year 2024 Results on Feb 12, 2025

Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?

Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?

Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of €0.35 per share

Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

First quarter 2024 earnings released: EPS: €0.27 (vs €0.21 in 1Q 2023)

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35

Jenoptik AG's (ETR:JEN) P/E Is On The Mark

Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's

Dividend increased to €0.35

At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?

Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult

Jenoptik AG to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Is Jenoptik (ETR:JEN) A Risky Investment?

Jenoptik AG, Annual General Meeting, Jun 18, 2024

Jenoptik AG to Report Fiscal Year 2023 Results on Feb 07, 2024

Why Jenoptik AG (ETR:JEN) Could Be Worth Watching

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?

Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?

Second quarter 2023 earnings released: EPS: €0.34 (vs €0.40 in 2Q 2022)

Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet

Upcoming dividend of €0.30 per share at 1.0% yield

First quarter 2023 earnings released: EPS: €0.21 (vs €0.055 in 1Q 2022)

Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Should You Think About Buying Jenoptik AG (ETR:JEN) Now?

Price target increased by 8.5% to €33.30

Price target increased by 8.4% to €32.20

Jenoptik AG to Report Q1, 2023 Results on May 11, 2023

Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly

Jenoptik AG, Annual General Meeting, Jun 07, 2023

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?

Jenoptik AG to Report Fiscal Year 2022 Results on Feb 15, 2023

Is Jenoptik (ETR:JEN) A Risky Investment?

When Should You Buy Jenoptik AG (ETR:JEN)?

Second quarter 2022 earnings: EPS exceeds analyst expectations

Price target decreased to €31.00

STAR Capital Partnership LLP completed the acquisition of VINCORION from Jenoptik AG (XTRA:JEN).

Investor sentiment deteriorated over the past week

Upcoming dividend of €0.25 per share

We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt

First quarter 2022 earnings: EPS misses analyst expectations

Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?

Jenoptik AG to Report Q1, 2022 Results on May 11, 2022

Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?

Now 21% undervalued

Investor sentiment improved over the past week

Jenoptik AG (XTRA:JEN) completed the acquisition of BG Medical Applications GmbH, SwissOptic AG and SwissOptic (Wuhan) Co., Ltd. from Berliner Glas KGaA Herbert Kubatz GmbH & Co.

Fund managed by STAR Capital Partnership LLP agreed to acquire VINCORION from Jenoptik AG (XTRA:JEN).

Third quarter 2021 earnings released: EPS €0.46 (vs €0.24 in 3Q 2020)

Is Jenoptik (ETR:JEN) Using Too Much Debt?